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Abstract 
The integral role of light in physiological and psychological well-being is illustrated by the 
application of phototherapy, or bright light therapy (BLT), in treating mood disorders such as 
seasonal affective disorder and non-seasonal depression.  More recently, BLT has been applied 
in treating jet lag due to transmeridian travel, complications from shift work, and disorders of 
sleeping and waking.  Despite the numerous potential applications of BLT, deleterious side 
effects have not been fully explored in a non-clinical population.  Thus, I examined the acute 
side effects (nausea, headache, blurred vision, eye strain) of a single 30-minute exposure of 
bright white light (10,000 lux) therapy and a comparison dim red light (<500 lux) in non-
depressed sample of young adults, with a focus on the potential moderating role of depressive 
symptoms.  Linear regressions revealed no significant main effects for light. However, self-
reported nausea and total side effect intensity significantly decreased in response to white light, 
but not red light, for those with greater depressive symptomatology.  In addition, a repeated-
measures analysis of variance revealed a significant group-by-time interaction for sad mood, 
which decreased at a higher rate in the white light condition compared to the red light condition.  
Also, a post-hoc analysis revealed a significant increase in eye strain for both conditions, with no 
significant difference between them.  These results suggest that the high prevalence of acute 
adverse side effects in the extant BLT literature may not fully apply to non-clinical populations.   
Keywords: Phototherapy, Illumination, Side Effects (Treatment), Safety 
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An Examination of the Acute Effects of Bright Light Therapy in a Non-Clinical Sample  
The United States Department of Health and Human Services (2000) reported that 
unhealthy lifestyles are responsible for most of the top ten cases of mortality and morbidity in the 
country.  Accordingly, lifestyle-based interventions carry considerable potential to prevent and 
ameliorate numerous forms of physical and mental illness (for review, see Walsh, 2011).  One 
such interventional strategy – the use of artificial bright light exposure to supplement the body’s 
reliance on sunlight for physiological and psychological well-being – has come into increasingly 
widespread use in recent decades (reviewed in Terman & Terman, 2005) based on its ability to 
influence circadian rhythms and neural signaling.  
Plants and animals entrain circadian rhythms through zeitgebers, the environmental cues 
that assist in regulation of an organism’s biological clock.  In animals, circadian rhythms assist 
the body in cyclical regulation of biochemical, physiological, and behavioral processes.  Light, 
the strongest zeitgeber for mammals, is processed through retinal ganglion cells of the eye 
containing specialized photoreceptors, which signal to the suprachiasmatic nucleus (SCN) in the 
brain’s anterior hypothalamus (Moore & Eichler, 1972; Stephan & Zucker, 1972) through 
photopigments such as melanopsin (for a review, see Rollag, Berson, & Provencio, 2003).  This 
pathway, designated the retinohypothalamic tract, wherein the SCN generates circadian rhythms, 
aids the body in directing the circadian clock and, in turn, assists the body in hormonal release, 
particularly melatonin (N-acetyl-5 methoxytryptamine) regulation (Berson, Dunn, & Takao, 
2002; Gooley, Lu, Chou, & Scammell, 2001; Hannibal, Hindersson, Knudson, George, & 
Fahrenkryg, 2002; Hattar, Liao, Takao, Berson, & Yau, 2002).   
Melatonin, synthesized from tryptophan and secreted by the pineal gland, assists in 
transmission of daily and seasonal circadian messages emanating from the SCN, while 
ACUTE SIDE EFFECTS OF LIGHT THERAPY 6
simultaneously contributing to numerous other physiological processes (for a review, see 
Goldman, 1999; Reiter, 1993; Simonneaux & Ribelayga, 2003).  Highlighting the reciprocal 
relationship with the SCN, melatonin production surges at night in response to diminished light.  
Similarly, as the SCN drives arousal and waking with the presence of light, its effects are 
counteracted by melatonin receptors in the SCN, triggering induction of sleep as light decreases 
(Challet, 2007).  Melatonin production and the retinohypothalamic tract illustrate the brain’s 
sensitivity to light, which derives from a hypothesized evolutionary mechanism designed to 
anticipate predictable cycling of physiology and behavior in response to environmental changes.  
Consequently, the chief cues for entrainment of the human circadian system, as a byproduct of 
evolutionary phylogenetic selection pressures, are sunrise and sunset. 
Animal models highlight the importance of light for healthy biological functioning.  For 
instance, rats kept in complete darkness develop neuronal damage and express depressive 
behaviors (Gonzalez, & Aston-Jones, 2008).  Similar biological evidence is found in human 
genetic research.  For example, individuals with major depression with seasonal onset pattern, 
commonly known as seasonal affective disorder (SAD), a disorder characterized by increase in 
depressive symptoms in the winter months when daylight hours are most limited, were recently 
found to be at least five times more likely to have a mutation in the gene responsible for 
melanopsin expression (Roecklein et al., 2009).  These findings illustrate the closely knit 
relationship between light and healthy physiological and psychological functioning.  The 
disturbance of normal biological rhythms, caused by disruption in light entrainment due to 
dysregulated sunlight exposure, has instigated further examination into the putative function of 
light as a treatment option for a range of lifestyle-linked maladies.   
ACUTE SIDE EFFECTS OF LIGHT THERAPY 7
Prescribed to treat a host of conditions, bright light therapy (BLT), or phototherapy, 
consists of exposure to daylight or artificial bright light for a determined period of time at a 
specific time of day.  Application of BLT has been examined in circadian phase sleep disorders, 
such as jet lag (Boulos et al., 1995) and shift work problems (Eastman et al., 1995), and disorders 
of sleeping and waking (Terman et al., 1995). Simultaneously, research on BLT has yielded 
particularly encouraging results in the treatment of SAD (for a review, see Terman & Terman, 
2005).  BLT has potential applications for treating other mood disorders, including major 
depressive disorder (MDD, [reviewed in Prasko, 2008]), bipolar disorder (Sit, Wisner, Hanusa, 
Stull, & Terman, 2007), antepartum and postpartum depression (Oren et al., 2002), and 
premenstrual dysphoric disorder (Krasnik, Montori, Guyatt, Heels-Ansdell, & Busse, 2005).  
Future potential applications have also been examined in treating behavioral disturbance and 
insomnia in dementia (Ancoli-Israel, Martin, Kripke, Marler, & Klauber, 2002), primary and 
secondary features of Parkinson’s disease (Willis & Turner, 2007), attention deficit hyperactivity 
disorder (Rybak, McNeely, Mackenzie, Jain & Levitan,  2006), seasonal variations in eating 
disturbances associated with bulimia nervosa (Lam, Goldener, Solyom, & Remick, 1994), and 
general symptom elevations found in chronic anorectic women (Daansen & Haffmans, 2010).  
Despite the potential for a wide array of application, the side effects and tolerability of BLT has 
not been extensively examined. 
The therapeutic effects of light have long been documented, with the medical use of 
sunlight tracing back to antiquity (Kellogg, 1910, 2003; Wehr & Rosenthal, 1989).  However, it 
gained popularity in the late 19
th
 century with Dr. J.H. Kellogg’s promotion of light treatment for 
an array of illnesses, including melancholia (Kellogg, 1910, 2003).  Light treatment also 
garnered a 1903 Nobel Prize for N.R. Finsen for his research on the treatment of lupus vulgaris.  
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Other skin-related problems treated by light therapy include acne vulgaris (Riddle, Terrell, 
Menser, Aires, & Schweiger, 2009), psoriasis (Walters, Burack, Coven, Gilleaudeau, & Krueger, 
1999), and eczema (Polderman, Wintzen, le Cessie, & Pavel, 2005).  However, light treatments 
for mental illness fell out of favor after the early part of the 20
th
 century due to a paucity of 
supporting empirical evidence.  
A resurgence of interest in the relationship between mental health and light developed 
with the work of Wetteberg (1978) and Lewy and colleagues (1980), who examined the effect of 
light on melatonin production.  Early intervention research targeted SAD with the first published 
study by Rosenthal and colleagues (1984).  In the interim, numerous published trials have refined 
and extended the treatment protocol.  Most such studies (e.g., Avery, Khan, Dager, & Dunner, 
1990; Lewy, Sack, Miller, & Hoban, 1987; Prasko et al., 2002; Sack et al., 1990; Terman et al, 
1990) show morning light to be superior to evening light, which reflects the natural diurnal 
variation in retinal photoreceptor sensitivity (Remé, Wirz-Justice, & Terman, 1991).  Based on 
these findings, phase-shifting of the brain’s circadian clock has been targeted as the hypothetical 
mechanism of light’s therapeutic effect.  Specifically, the putative biological mechanism for BLT 
to treat depressive symptoms is through the suppression of melatonin production in the brain, 
which may induce a therapeutic alteration of dysregulated circadian rhythms (Lewy, Wehr, 
Goodwin, Newsome, & Markey, 1980).    
Altering neurotransmitters circuitry may provide an alternative mechanism underlying 
the therapeutic effect of bright light exposure.  Sunlight directly influences serotonin turnover in 
the brain, with the lowest rate of turnover in the winter, and more rapid turnover with increased 
luminosity (Lambert, Reid, Kaye, Jennings, & Esler, 2002).  Similarly, BLT increases serotonin-
based central nervous system activity in depressed individuals (Rao et al., 1992).  Furthermore, 
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individuals with bipolar disorder who are homozygotic for the long variant of the serotonin 
transporter-linked polymorphic region (5-HTTLPR), speculated to be involved in stress 
sensitivity (Caspi, Hariri, Holmes, Uher, & Moffitt, 2010), show longer-lasting mood elevation 
after a combination of BLT and sleep deprivation, in comparison with heterozygotes and 
homozygotes for the short variant (Bendetti et al., 2003).  Studies with BLT have also indicated 
some dopamenergic effects in the brain (Neumeister et al., 2001; Oren, 1991). 
 BLT has likewise proven beneficial in the treatment of sleep disorders.  In advanced 
sleep phase syndrome (ASPS), individuals experience early waking and difficulty remaining 
awake in the evening.  Conversely, in delayed sleep phase syndrome (DSPS), individuals 
experience sleep onset insomnia, or difficulty initiating sleep, and problematic morning 
awakening. Such sleep disorders maintain a misalignment of sleeping and waking compared to 
the individual’s circadian clock.  Selective application of bright light in the morning (to correct 
DSPS) or in the evening (to correct ASPS) has been effective in instituting normal sleep-wake 
cycles (for a review, see Gooley, 2008), as appropriately-timed exposure to bright light can shift 
the sleep-wake cycle to earlier or later times in order to align a disruption between the circadian 
system and desired sleep-wake schedule.  Application of this methodology has been applied to 
other circadian disorders, including non-24-hour sleep-wake disorder, where the sleep-wake 
cycle is free-running, and shift work sleep disorder, where insomnia occurs during the day and 
fatigue during nighttime for individuals who must remain awake at night (for a review, see 
Gooley, 2008).  Similarly, Jet Lag Disorder (JLD), a circadian rhythm sleep disorder 
characterized by insomnia or excessive daytime sleepiness in response to transmeridian jet travel 
that alters typical rhythm, has been treated successfully with BLT (Boulos et al., 1995).  Overall, 
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the treatment of circadian rhythm sleep disorders with BLT has been successful due to the brain 
and body’s acute sensitivity to light. 
Researchers (e.g., Wirz-Justice, Benedetti, & Terman, 2009) now generally recommend 
that BLT be administered via a light box protocol tested successfully in peer-reviewed clinical 
trials.  The optimal length and luminance of light exposure is 10,000 lux (a unit of illumination 
equal to a luminous flux of 1 lumen per square meter) at a comfortable sitting distance, usually 
12-14 inches from the participant’s eyes, for a period of 30 minutes (Terman et al. 1990; Terman, 
Terman, & Ross, 1998).  However, lower light intensities can be effective if applied for longer 
durations (Eastman, Young, Fogg, Liu, & Meaden, 1998; Lewy et al., 1998), as researchers have 
observed an inverse relationship between length of light presentation and strength of light when 
reviewing treatment efficacy.  Light boxes should utilize fluorescent bulbs and a screen that 
filters out ultraviolet (UV) rays, which are harmful to the eyes and skin.  The lamps should emit 
white light rather than colored light because, so far, colored light lamps have not been 
unequivocally shown to provide a therapeutic advantage (for a review, see Anderson, Glod, Dai, 
Cao, & Lockley, 2009) and may have possible deleterious side effects (Bynoe, Del Priore, & 
Hornbeck, 1998; Ham, Mueller, & Sliney, 1976; Remé, Williams & Rol, 1998; Wu, Seregard, & 
Algvere, 2006).  The projection of light should be maintained downward toward the eyes at an 
angle to minimize aversive visual glare and to provide maximal therapeutic effect (Glickman et 
al., 2003).  The timing of BLT throughout the course of the day differs depending on the targeted 
malady.  For example, to avoid triggering a manic episode, individuals with bipolar disorder are 
advised to apply BLT in the afternoon rather than the morning (Leibenluft et al., 1995; Sit et al., 
2007).  Generally, BLT for MDD or SAD is applied in the morning, unless individuals 
experience difficulty with sleep onset.  Similarly, application of BLT for JLD, shift work 
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problems, and disorders of sleeping and waking, will differ contingent on a need for either 
forward or backward circadian realignment. 
Within five years of Rosenthal and colleagues’ (1984) work on treating depressive 
symptoms with BLT, 25 published studies already attested to the potential efficacy of light 
therapy for SAD (Terman et al., 1989), and a subsequent meta-analysis of randomized, 
controlled trials of BLT for the American Psychiatric Association Committee on Research in 
Psychiatric (Golden et al., 2005), using strict criteria for only the most methodologically sound 
trials, concluded that BLT is superior to placebo in reducing symptoms of SAD, with an effect 
size of 0.84.  In fact, remission rates were found to be nearly three times higher (Odds Ratio of 
2.9) among BLT patients in comparison with those receiving placebo.  Similarly, a meta-analysis 
(Even, Schröder, Friedman, & Rouillon, 2007) found the response to BLT was significantly 
better than control treatment among high-quality, methodologically sound studies and in those 
studies that applied morning light treatment to non-seasonal depression.  Likewise, when limiting 
their evaluation to the most methodologically sound studies, Golden et al. (2005) found that BLT 
was an effective stand-alone treatment for non-seasonal depression, with an effect size of 0.53.  
Furthermore, Golden and colleagues noted that this observed effect size is similar to that of most 
antidepressant medication trials.  In summary, there is considerable published evidence that 
retinal exposure to light of sufficient intensity and duration, at an appropriate time of day, can 
have marked effects on the affective and physiological symptoms of seasonal-onset depressive 
illness, with a likely therapeutic benefit for non-seasonal depression as well.   
However, despite promising findings of the effectiveness of BLT in treating depressive 
illness, psychotropic medication is currently the most commonly prescribed treatment for 
depression (Sleath & Shih, 1998), with about 164 million antidepressant prescriptions written in 
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the United States to 27 million individuals (Olfson & Marcus, 2009).  Selective serotonin 
reuptake inhibitors (SSRIs), the newest and most popular type of antidepressant medication, and 
serotonin and norepinephrine reuptake inhibitors (SNRIs), which are similar to SSRIs, induce 
side effects that include headache, gastrointestinal effects, akathisia or restlessness, agitation, 
hypomania and, possibly, sexual dysfunction (Schatzberg, Cole, & DeBattista, 1997).  SSRIs and 
SNRIs constitute a second generation of antidepressants that do not provide a therapeutic 
advantage over first generation antidepressants but are considered more tolerable (Anderson, 
2008).  Side effect rates differ between medications; however, estimates show that as many as 
86% of those taking antidepressant medications will experience at least one side effect (Hu et al., 
2004).  Antidepressants can also cause, though rarely, potentially life-threatening cases of 
seizures and agranulocytosis (for a review, see Mago, Mahajan, & Thase, 2008).  Another 
potentially life-threatening side effect of SSRIs is serotonin syndrome, a condition caused by 
elevated serotonin in the body (Boyer & Shannon, 2005).  
Antidepressants have also been scrutinized due to their potential deleterious side effects 
on adolescents and young adults. The Food and Drug Administration (FDA, [Lenzer, 2006]) 
conducted a review of published and unpublished controlled clinical trials of antidepressants and 
revealed that 4% of those taking antidepressants thought about or attempted suicide compared to 
2% of those receiving a placebo.  These findings have prompted the FDA to mandate that 
antidepressants carry a “black box” label warning of their potential to increase suicidality in 
children and adolescents (Friedman & Leon, 2007) and a proposal was made to extend the 
warning to include young adults up through age 24 (Stone et al., 2009). Such recorded 
unpleasant side effects can interfere with treatment and rates of discontinuation of treatment vary 
from 5-39% due to adverse effects from SSRIs (Ruhé, Huyser, Swinkels, & Schene, 2006). 
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The findings of intolerability and discontinuation of treatment due to adverse effects of 
medication, combined with the use of BLT to treat both affective and non-mental health ailments, 
warrants further research to help clarify the tolerability and prevalence of side effects of BLT.  
Despite the numerous potential applications of BLT, deleterious side effects have not been fully 
explored.  Although Gallin and colleagues (1995) have provided evidence for the 
ophthalmologic safety of bright light in both long term and short term application, and no 
difference has been found in cone and rod functioning with BLT compared to typical indoor light 
(Gagné, Gagné, & Hébert, 2007), sparse evidence has been collected on incidence and 
tolerability of undesired side effects. 
The most extensive examination of the adverse effects of BLT using the currently 
prescribed dosage and length of exposure, 10,000 lux for 30 minutes, was conducted by Kogan 
and Guilford (1998).  Researchers controlled for symptoms present before the study and using a 
self-report of symptoms from a checklist found that 32 out of 67 participants undergoing an 
average of 6.8 sessions reported side effects, with nine individuals reporting two or more.  About 
20% of participants reported either headaches or eye/vision difficulties.  This finding supports 
those of Oren and colleagues (1991) and Labbate and colleagues (1994), who concluded that 
headache and eye/vision difficulties, while occurring at only slightly higher rates, were the most 
common side effects.  Terman and Terman (1999) also found headaches and eye/vision vision 
difficulties as prominent concerns, with an addition of nausea as another potential chief side 
effect.  Avery and colleagues (2001) found headache as the most common side effect, one 
reported by 10 % of their sample.  Unfortunately, each of the aforementioned studies lacked a 
control group, thereby limiting the interpretability of their findings.   
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Volz, Mackert, and Stieglitz (1991) conducted the only placebo-controlled study that 
directly addressed the issue of adverse effects with BLT.  Employing a control group of 50 lux 
red light compared to 2500 lux white light for two hours a day over seven consecutive days, the 
study found no significant differences in any reported side effects between groups; notably, 
however, the dosage of light and length of presentation employed in this study vary from the 
current most widely prescribed dosage and length (i.e., 10,000 lux for 30 minutes).   
The most severe adverse effects have been identified in individuals with bipolar disorder, 
and studies (e.g., Leibenluft et al., 1995; Sit et al., 2007) have identified a potential increased risk 
of triggering hypomania with morning exposure.  Rare cases of mania and hypomania have also 
been noted in individuals treated for non-seasonal depression (Bauer, Kurtz, Rubin, & Marcus, 
1994; Kripke, 1991; Schwitzer, Neudorfer, Blecha, & Fleischhacker, 1990).   
BLT has also been employed as a non-pharmacological adjunct to antidepressant 
medication (e.g. Kripke, Mullaney, Savides, & Giltin, 1989; Levitt, Joffe, & Kennedy, 1991).  
To examine the side effects of such adjuvant BLT usage, Muller and colleagues (1997) studied 
28 non-seasonally depressed participants assigned to four weeks of pharmacotherapy 
(Trimipramine) or pharmacotherapy and BLT, with the bright light treatment group receiving 
5000 lux exposure for two hours per day.  No significant differences in overall side effect 
prevalence were observed between groups, but investigators found a dissimilar side effect profile 
in each group.  Specifically, both groups showed differential ameliorating and aggravating 
somatic complaints that were impossible to disentangle from depressive symptoms, a finding 
which highlights the difficulty of assessing adverse treatment effects from a clinical population.   
Individuals with MDD often (75%) report somatic complaints (Vaccarino, Sills, Evans & 
Kalali, 2009), and MDD is the most frequent comorbid diagnosis of patients with somatization 
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syndromes (Katon, 1984; Katon, et. al., 1991; Rief, Schaefer, Hiller & Fichter, 1992).  For 
example, Terman and Terman (1999) reported an array of undesired physiological symptoms in 
individuals with SAD present before application of BLT, many of which remitted during 
treatment.  In other words, these investigators observed among seasonally depressed patients a 
BLT-induced reduction in some depression-linked physical complaints that are often otherwise 
measured as potential “side effects” of bright light exposure. Thus, utilizing clinical samples to 
examine adverse effects of BLT may yield results that do not readily generalize to non-clinical 
populations.  
Few studies have examined the effect of BLT on non-clinical populations, and none have 
reported directly on the potential adverse effects that may occur in these populations.  However, 
as previously reviewed, we know in general that exposure to bright light is associated with 
physiological changes, such as direct serotonin turnover in the brain, melatonin reduction, and 
muscular eye movement.  Depressed individuals may experience an amplified perception of 
these physiological changes, or may be more prone to interpret these changes as adverse or 
undesired physical symptoms stemming from greater vigilance regarding negative information 
(Erickson et al., 2005).   Similarly, individuals with depressive symptomatology may be more 
likely to interpret physiological changes as aversive.  For example, compared to controls 
individuals with MDD are hypersensitive to heat stimuli in sensory and the affective
 
dimensions, 
a bias particularly apparent in the innocuous heat range (Strigo, Simmons, Matthews, Craig & 
Paulus, 2008a).  Also, increased emotional reactivity of anticipatory pain may lead to impaired 
ability to modulate pain experience in MDD, as been shown with heat stimuli (Strigo, Simmons, 
Matthews, Craig & Paulus, 2008b).  Recent research (Lozano et al., 2008) has also indicated a 
potential role of the anterior cingulate cortex in depression leading to an inability to cognitively 
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contain negative stimuli.  Converging lines of evidence point to an increased affective and 
neurological bias
 
for non-noxious stimuli in depressed populations, which may be paralleled in 
over-reporting of adverse effects in interventions such as BLT.  Thus, further investigation is 
necessary to elucidate the potential effect of depressive symptomatology on the report of side 
effects after bright light exposure. 
Across relevant published reports of BLT side effects, the most commonly reported 
problems were considered mild and transient, and did not interfere with treatment indicating an 
acceptable tolerability of side effects.  Furthermore, reports of side effects were also reduced 
with repeated exposures.  For example, Kogan and Guilford (1998) reported that on the first day 
of BLT, 24 participants (34.3%) reported side effects, which decreased to 17 (24.3%) by the 
second day.  By day three only 12 individuals (17.9%) reported side effects, and by days four 
and five, fewer than 10% of the participants reported side effects.  Headaches, with one 
exception, ceased after the third day and few eye/vision problems occurred after the second day.   
The purpose of the present investigation is to evaluate the side effect profile of one-
session BLT compared to a dim red light, while accounting for the potential moderating effect of 
depressive symptomatology.  An extensive literature search did not reveal any placebo-
controlled studies utilizing the currently prescribed dosage and duration (10,000 lux for 30 
minutes) of BLT.  Similarly, no research has evaluated the potential moderating effect of 
depressive symptomatology on the report of side effects, or utilized a non-clinical sample to 
examine side effect, or examined the acute side effects of a single session exposure of bright 
light.  Sampling from a non-clinical population allows for greater safeguards against the 
somatization effect often observed in clinical samples.  With increased use of BLT in non-
clinical samples it becomes more important to understand the effect of depressive 
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symptomatology on the report of side effects.  Since previous research has shown that most side 
effects emerge during or immediately after the initial session, and diminish with repeated 
exposures, the present study evaluated the side effects associated with only one session at the 
currently prescribed dose and luminance (10,000 lux for 30 minutes). Since it is hypothesized 
that depressive symptomatology has a moderating effect on reporting of side effects, positive and 
negative affect were also measured in order to permit an ancillary examination of BLT’s acute 
effects on mood.   
The chief objective of this study was to examine the tolerability and side effects of a 
single session of bright light exposure. Primarily, this experiment investigated how applying 30 
minutes of 10,000 lux white light affects somatic domains relevant to normal daily functioning.  
My principal study hypothesis was that depressive symptomatology moderates the experience of 
side effects with BLT, with an increased perception of side effects associated with increased 
depressive symptomatology in the bright light, but not the control, condition.  Since previous 
findings have demonstrated BLT’s salubrious mood effects even among healthy individuals (e.g. 
Partonen & Lönnqvist, 2000), BLT was also expected to decrease negative affect at a greater rate 
from pre-treatment to post-treatment compared to red light. 
Method 
Participants 
Participants were recruited from the University of Kansas participant pool as a course 
requirement.  All participants were students in an introductory psychology class; however, 
introductory psychology serves as an option for students to complete a General Education 
requirement allowing students from various majors to enroll. All participants provided written 
informed consent and the study was approved by the Institutional Review Board. The exclusion 
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criteria were a history of depressive disorders, bipolar disorder, or retinal light sensitivity.  
Participants were excluded from the final analyses if they reported consuming more than five 
alcoholic beverages over the previous 24 hours and if they endorsed all of the symptoms on a 
side effects questionnaire prior to treatment.   
Materials 
 Artificial bright light was emitted by a Sunlight Jr. (The Sunbox Company, Gaithersburg, 
MD) light box.  The Sunlight Jr. is a triangular shaped light box (14.5" Tall x 7" Wide (Face) x 
6" Sides) that emits a full spectrum of light and employs a spectrally transparent prismatic 
diffuser to block UV rays.  At a distance of 14 inches the light box emits a luminance of 10,000 
lux.  A red filter was positioned over the prismatic diffuser to filter all but red light and reduce 
the luminance to less than 500 lux at a distance of 14 inches. 
Procedures 
After the consent process, participants were excluded if they endorsed eye sensitivity to 
light or a history of depressive disorder or bipolar disorder.  Participants completed an 
assessment battery and then randomly assigned either to the bright light condition (10,000 lux) or 
the low-level red light condition (less than 500 lux) after meeting study criteria.  Participants 
were informed that the goal of the study was to examine the effect of different types of light on 
their responses to the questionnaires.  To receive light exposure, individuals were seated alone in 
a room at a table with a light box positioned 14 inches from their eyes, above their head, and 
facing them at a 45 degree angle.  All sessions occurred between 8 and 11 AM in a room 
unexposed to natural light.  Additionally, the experiment room’s fluorescent overhead lighting 
was dimmed to approximately 50 lux.  During the 30-minutes exposure, the participants were 
instructed to read popular culture and/or current events magazines provided by the experimenters 
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and to always maintain their gaze forward.  An experimenter assessed adherence to instructions 
throughout the session but did not interact with the participants in any other capacity. After the 
30-minute exposure, participants completed another assessment battery.  Data collection began 
in November, 2010 and spanned through the end of May, 2011. 
Measurements 
The Quick Inventory of Depressive Symptomatology – Self Report (QIDS) is a 16 item, 
self-report questionnaire designed to assess the severity of depressive symptoms (Rush et al. 
2003). The QIDS assesses all the criterion symptom domains designated by the Diagnostic and 
Statistical Manual of Mental Disorders - 4th edition (DSM-IV [APA, 1994]) to diagnose a major 
depressive episode.  Each item is scaled 0–3, with 0 as the least severe and 3 as the most severe.  
QIDS spans a 7-day period prior to assessment as the time span for assessing symptom severity.  
Total scores range from 0-27 with scores indicating mild (6-10), moderate (11-15), severe (16-
21), and very severe (21-27) depression.  Content validity derives from QIDS items that rate the 
nine symptom domains used to define a major depressive episode (APA, 1994).  The QIDS has 
been shown concurrent validity with the Hamilton Rating Scale for Depression and to have high 
internal consistency (Lamoureux et al., 2010; Rush et al. 2003).  The QIDs was utilized because 
it is the most recently validated tool for depression that has been used with regionally and 
ethnically diverse samples (Trivedi et al., 2004), 
The Toronto Side Effect Scale (TSES) is a 32-item clinician-rated instrument that 
measures adverse events (Voanderkooy, Kennedy, & Bagby, 2002) measuring frequency (never 
– everyday) and severity (no trouble – extreme trouble) on a 5-point scale.  The product of the 
severity and frequency scale produce an “intensity” score.  The TSES has been modified for the 
present study due to a dearth of rating scales for side effects (Wisniewski, Rush, Balasubramani, 
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Trivedi, & Nierenberg, 2006) and the propensity for the TSES to be modified to suit a study’s 
goals (e.g. Thomas et al., 2008; Zimmerman et al., 2010).  The modified TSES is 19-item self-
report measure of presently perceptible physiological symptoms excluding those items originally 
intended to measure side effects that are not applicable to BLT (e.g. sexual dysfunction, weight 
loss/gain) with an addition of symptoms relevant to light therapy (e.g. irritability, eye strain).  
Each symptom has been modified to a binary choice assessing the presence or absence of a 
symptom while the severity scale has been preserved.  A total side effect intensity score is 
produced with the sum total of severity endorsements. 
The Profile of Mood States (POMS) is a validated self administered measure of mood 
disturbance within six domains, including, fatigue-inertia, vigor-activity, tension-anxiety, 
depression-dejection, anger-hostility, and confusion-bewilderment (McNair, Lorr, & 
Droppelman, 1971).  The scale ranges from 0 to 4 for each item, with 0 indicating that the item 
was not at all accurate in describing how the participant felt, and 4 indicating that the item was 
extremely accurate in describing how an individual is feeling.  The POMS was modified to a 28-
item checklist of adjectives and negative affect was measured based on two categories: anxiety 
(including on edge, nervous, and tense) and sad mood (including unhappy and sad). Positive 
affect was measured using three categories: vigor (including full of pep, energetic, and lively), 
well being (including happy and cheerful), and calm (including calm and relaxed).  Concurrent 
validity of the POMS has been shown with the Visual Analog Mood Scale and concurrent 
validity of subscales on the POMS with the Beck Depression Inventory, State-Trait Anxiety 
Inventory, and the Geriatric Depression Scale (Nyenhuis, Yamamoto, Luchetta, Terrien & 
Parmentier, 1999).  Internal Consistency Reliability for the full-length POMS has ranged from 
0.74 to 0.91 (Shacham, 1983), and shortened versions of the POMS similar to the version used in 
ACUTE SIDE EFFECTS OF LIGHT THERAPY 21
the current study have been found to have similar internal consistency (Bourgeois, LeUnes, & 
Meyers, 2010).  
Statsitical Analyses  
All analyses were conducted using PASW Statistics 18, Release Version 18.0.0 (SPSS, 
Inc., 2009, Chicago,IL, www.spss.com).  First, the presence of potentially confounding between-
group differences on demographic (gender, age) and clinical characteristics (depressive 
symptoms, sleep quality, physiological symptoms present prior to light exposure, and mood prior 
to light exposure) were tested by means of univariate analyses of variance.   
To investigate moderation of the associations between light condition and side effects by 
depressive symptoms, multiple regression analyses were performed.  In such analyses, computed 
pre-post change scores in total side effect intensity and severity of the four most commonly 
reported side effects of light therapy - headache, eye strain, blurred vision, and nausea – were 
used as dependent variables.  Each score was calculated as the difference of the post-treatment 
and pre-treatment scores on the TSES. Condition (bright light, red light), centered QIDS scores, 
and a condition-by-QIDS interaction term served as independent variables of interest.  
Depressive symptomatology was measured using the QIDS and centered for the analyses to 
increase interpretability of interactions (Aiken & West, 1991).  An interaction term was created 
as the product of the centered continuous predictor (QIDS) and the categorical predictor 
(condition).  Each regression analysis consisted of two steps.  In the first step, condition and the 
centered QIDS was regressed on the dependent variable.  In the second step, the interaction term 
was added to the model.  A moderating effect was considered present when the interaction term 
was statistically significant within a statistically significant model. An alpha level of .05 was 
utilized in all regression analyses. 
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A within-subjects, repeated measures, 2x2 factorial design using time (pre, post) by 
condition (bright light, red light) was used to analyze mood-related effects.  Specifically, main 
effects of time (pre-post) and condition, as well as a time-by-condition interaction effect, were 
analyzed using a repeated measures analysis of variance (ANOVA) for negative affect, positive 
affect, sad mood, and anxiety.  An alpha level of .05 was utilized in all analyses.   
Finally, simple between-group differences in specific side effects were analyzed by 
means of paired sample t-tests with a Bonferroni correction, and a within-subjects, repeated 
measures, 2x2 factorial design – time (pre, post) by condition (bright light, red light) – was used 
to analyze changes in total side effect intensity and nausea severity.  
Results 
 One hundred and forty-eight undergraduate students (53% female, mean age = 19.51) met 
criteria for the study and were included in the final analyses.  Seventy-seven (52%) participants 
were randomized into the control, red light group.  Means, range, and standard deviations for 
other variables of interest are provided in Table 1. Univariate analyses of variance revealed no 
significant preexisting differences in baseline characteristics between participants in the two 
experimental conditions.  Table 2 presents the prevalence of reported side effects at pre-
treatment and post-treatment within each condition. 
Five separate multiple regression models were evaluated to determine the effects of 
experimental condition and depressive symptomatology on reported side effects; standardized 
betas, unstandardized betas, and the standard error for unstandardized betas are provided in 
Table 3.  The regression model with condition, QIDS score (depressive symptoms), and the 
condition-by-QIDS interaction term significantly predicted change in severity of nausea and 
change in total side effect intensity.  The condition-by-QIDS interaction term was statistically 
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significant in the prediction of total side effect intensity; likewise, the interaction had a 
significant effect for nausea severity.   Adjusted R-squared for the change in nausea severity 
was .044; in other words, about 4.4 % of the variability in nausea severity change score was 
accounted for by the model.  Adjusted R-squared for the change in total side effect intensity 
was .089; thus, about 8.9 % of the variability in the difference in the total intensity of side effects 
was accounted for by the model.  No significant main or interaction effects emerged for 
headache, blurred vision, or eye strain.   
Figure 1 presents a plot of the moderation effect between low QIDS scores (1 SD below 
the mean) and high QIDS scores (1 SD above the mean) for total side effect intensity and Figure 
2 presents a plot for the moderation effect in severity of nausea.  For both interactions, the effect 
of light condition depends on the participant’s level of depressive symptomatology.  To further 
examine the nature of these interactions, separate subgroup analyses were conducted to evaluate 
the relationship between the QIDS and side effects.   In these analyses, the QIDS-side effect 
intensity association was significant for the bright white light group (β = -.436, p < .001) but not 
for dim red light group (β = .02, p >.85).  Similarly, the QIDS-nausea severity relationship was 
significant for the bright white light group (β = -.406, p < .001) but not for dim red light group (β 
= .1, p > .39).  The results indicate that as QIDS scores increase, bright white light decreases 
nausea severity and total side effect intensity, while dim red light does not.  A post hoc analysis 
was also conducted to compare overall changes in total side effect intensity and nausea severity 
across time (pre-treatment to post-treatment) by light condition. A within-subjects, repeated 
measures, 2x2 factorial design revealed no significant main effects or time-by-condition 
interaction on total side effect intensity.  Means and standard deviations for side effect intensity 
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are provided in Table 4.  Similarly, no significant main effects or interaction effect were 
observed for nausea. 
Table 5 presents the results of the two-way (time x light condition) ANOVAs utilizing 
mood state as the dependent variable. Examination of the effect of light on negative affect (the 
composite of anxiety and sad mood) yielded a significant main effect of time, such that the 
average post-treatment score (M = 0.54, SD = 1.32) was significantly lower than at pre-treatment 
(M = 1.01, SD = 2.05).  Similarly, a main effect of time emerged for positive affect, wherein 
average post-treatment scores (M = 7.47, SD = 4.94) were lower than pre-treatment (M = 8.52, 
SD = 4.89), and anxiety (pre-treatment: M = 0.47, SD = 1.37; post-treatment: M = 0.19, SD = 
0.72).  Main effects of condition and interaction effects were non-significant for these dependent 
variables.  A main effect of time also emerged for sad mood, such that the average post-treatment 
score (M = 0.37, SD = 0.85) was significantly smaller than pre-treatment (M = 0.55, SD = 1.06).  
Furthermore, the time-by-condition interaction effect (Figure 3) was also significant for sad 
mood, indicating that sad mood decreases at a greater rate post-treatment in the bright white light 
group (M = 0.35, SD = 0.79)  compared to the dim red light group (M = .39, SD = .91). 
Finally, following an inspection of prevalence rates for each side effect, post hoc analyses 
were conducted to test for a significant increase in the most common side effects in the study 
sample – eye strain, blurred vision, or headache – from pre-treatment to post-treatment.  To 
prevent inflation of Type I error rate a Bonferroni adjustment for level of significance, .017 
(.05/3), was applied.  There was a significant effect of time for eye strain, t(147) = -4.907, p 
< .001, such that the average post-treatment eye strain intensity (M = .921, SD = .076) was 
greater than at pre-treatment (M = .523, SD = .043).  There was no significant effect for blurred 
vision (t(147) = -1.589, p > .49) or headache (t(147) = -.675, p > .11). 
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Discussion 
 The present investigation represents the first placebo-controlled study of bright light 
therapy (BLT) side effects at the most widely recommended and utilized dosage and duration 
(10,000 lux for 30 minutes).  Similarly, this study is the first to evaluate a potential moderating 
effect of depressive symptomatology on the report of side effects, the first to examine side 
effects of BLT in a non-clinical sample, and also the first to examine the acute side effects of a 
single session exposure of bright light.  The potential usefulness of addressing such questions is 
highlighted by the increasingly widespread use of BLT with non-clinical populations for short 
periods of time (e.g., Boulos et al., 2002).  
There was no main effect of condition on report of side effects.  However, as 
hypothesized, exposure to bright white light – but not dim red light – had a differential effect on 
perceived side effect intensity when moderating for depressive symptomatology. Contrary to 
expectations, however, bright white light actually induced a pre-post reduction in reported side 
effects among individuals with higher baseline depressive symptomatology.  In other words, 
among participants in the bright light condition, those who had elevated depressive symptoms 
tended to report significantly lower overall side effect severity after light exposure than they did 
at the baseline assessment prior to exposure; this pattern was not observed in the red light 
condition.  Based on mean QIDS score the sample likely contains a subset of individuals who 
experienced clinically significant depressive symptoms and those suffering from dysphoria.  In 
more detailed analyses of pre-post changes among the most commonly reported phototherapy 
side effects – nausea, headache, blurred vision, and eye strain – the aforementioned light 
condition-by-depression interaction was only significant with respect to nausea.  That is, 
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participants with higher depressive scores tended to report reduced nausea after exposure to 
white light.  
While not expected in the present investigation, the potential ameliorating effect of BLT 
has been previously reported in the literature.  Specifically, Terman and Terman (1999) 
concluded that within their sample of seasonally depressed patients, treated for 10-14 days with 
BLT, side effect remission rates (from pre-treatment to post-treatment) generally equaled or 
exceeded the rate of side effect emergence.  Although they did not explicitly examine the side 
effects of BLT, the findings of other previous investigations using clinical samples may also be 
relevant.  For example, there appears to be an increase in general physical and psychological 
well being in women with anorexia nervosa (most of whom also had elevated depressive 
symptoms) after BLT (Daansen & Haffmans, 2010).  Potentially, an effect similar to the one 
seen in this study – an interaction between high depressive symptomatology and BLT - led to a 
reduction in undesirable physical symptoms and, thus, improvement in physical well-being.  A 
similar mechanism may also help explain the reported reduction in agitation and dyskinaesia due 
to BLT in individuals with Parkinson’s disease (Willis & Turner, 2007).   
Many principal side effects of interest – eye strain, blurred vision, and headache – were 
not differentially altered in response to light condition.  Likewise, there was no significant pre-
post increase in the study’s aggregate (composite) side effects measure as a function of bright 
light exposure.  Although such findings run counter to those of many previous reports (e.g., 
Kogan & Guilford, 1998; Labbate et al., 1994; Oren et al., 1991), the present results replicate 
those of the only other placebo-controlled study that primarily examined adverse effects of BLT. 
Volz and colleagues (1991), found no difference in side effects between a bright light and a dim 
red light condition.  However, the current findings are the first to replicate those of Volz and 
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colleagues using the currently prescribed dosage and length and the first to use a non-clinical 
sample.  Across both groups, only eye strain severity was significantly exacerbated from pre-
treatment to post-treatment, which is consistent with previous research indicating that eye strain 
is a potential concern of BLT.  However, this study demonstrated that eye strain is not a 
consequence of the luminosity or color of light.  
Although previous studies (e.g., Kogan & Guilford, 1998; Labbate et al., 1994; Oren et 
al., 1991) have reported blurred vision as a likely side effect of BLT, the contradictory current 
findings may stem from this study’s categorical division of blurred vision and eye strain as 
distinct side effects, as opposed to previous studies that conflated eye and vision problems in a 
single item.  The current findings establish a potential delineation in eye-related side effects that 
future studies should continue to examine.  Interestingly, only eye strain was significantly 
exacerbated from pre- to post-treatment in the present study, but the increase was equivalent 
across the red and white light groups.  Previous uncontrolled studies could not provide 
specificity regarding the cause of increased eye strain, which this study provided.  Specifically, 
the current results suggest that 30 minutes of exposure to an artificial light source - no matter the 
strength of luminance and either red or white coloration – will increase eye strain, but not blurred 
vision.   
The current finding of a decrease in nausea severity in those with high depressive 
symptomatology differs somewhat from that of Terman and Terman (1999), who found that in 
most study patients the emergence of nausea was more frequent than its remittance among 
individuals with SAD.  The investigators also found that non-responders to BLT were equally 
likely to report the emergence or remission of nausea, but that those receiving evening light were 
much more likely to report the emergence of nausea than those receiving morning exposure.  It is 
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possible that Terman and Terman would have observed higher remission rates for nausea among 
the subset of study non-responders who received morning BLT exposure, but they reported no 
analyses germane to this possibility.  Alternatively, the present study’s finding of an anti-nausea 
effect of BLT might be attributable to the use of a young, non-clinical participant sample, or 
perhaps to the use of a single session of BLT exposure rather than daily exposure over the course 
of several days. 
 As hypothesized, BLT was also observed to have a mood-restorative effect, such that sad 
mood showed a significantly greater pre-post reduction among those in the white light condition 
than those exposed to the control red light.  This result is consistent with previous findings (e.g., 
Partonen & Lönnqvist, 2000) of a decrease in depressive symptoms with BLT in a non-clinical 
sample.  However, this is the first study with a non-clinical sample and a light-placebo control to 
show an effect immediately after a single session of BLT.  The present finding provides further 
support not only for the clinical use of BLT, but also for its use in non-clinical populations – an 
important consideration, inasmuch as up to 10% of young adults report consistently low mood in 
the winter, but only a small subset meet the full diagnostic criteria for SAD or other mood 
disorders (Wicki et al., 1992).  The acute improvement of sad mood via BLT may have a 
beneficial effect in everyday life and, thus, potential implications for preventing depressive 
illness (Bar, 2009).  Accordingly, the present findings, if replicated, might point to a distinct new 
application of BLT – the reduction of dysphoria among otherwise healthy individuals. 
The rapidly observed mood-restorative effect of bright light exposure in this study is not 
likely attributable to BLT’s circadian phase shifting effect, which would not generally be evident 
until the surge of melatonin release in the evening.  Rather, the present results are consistent with 
an acute biological-change theory.  As previously shown, sunlight exposure directly enhances 
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serotonin turnover in the brain (Lambert et al., 2002), and BLT likewise increases serotonergic 
activity in depressed individuals (Rao et al., 1992).  Thus, the acute mood-restorative effects of 
BLT may also derive from increased serotenorgic activity.  In fact, similar acute effects of BLT 
have been reported in other studies (Kripke, Risch, & Janowsky, 1983; Sher et al., 2001). 
Intriguingly, BLT has also been shown to prevent the lowering in mood typically observed 
following acute tryptophan depletion (aan get Rot, Benekelfat, Boivin, & Young, 2008) – a 
procedure which reduces central serotonergic activity.  Notably, however, not all relevant 
investigations have reported mood-restorative effects with BLT among depressed (Bauer et al., 
1994) and non-depressed (Rosenthal, Rotter, Jacobsen, & Skwerer, 1987; Kasper, Rogers, 
Madden, Joseph-Vanderpool, & Rosenthal, 1990) samples. Such effects may be more difficult to 
assess in depressed individuals due to the very high intensity of sad mood at baseline, which 
could require repeated exposures of BLT to show a significant detectable effect.  Moreover, prior 
studies often used lower intensity light exposure for longer duration, as opposed to the currently 
prescribed dosage. 
The study’s finding of an anti-emetic effect – i.e., a reduction in nausea – with bright 
light among more depressed participants is somewhat surprising, especially since serotonin 
antagonists are used to treat nausea, and BLT serves as a serotonergic agonist. However, similar 
anti-nausea effects have previously been reported with BLT.  For instance, participants 
undergoing acute tryptophan depletion in a dim light control condition reported nausea from the 
procedure, and yet those who were exposed to bright light did not (aan get Rot et al., 2008).  
Since the potential serotonergic effects of BLT are not mediated via the intestinal serotonin 
receptors – but, rather, those of the central nervous system – bright light may affect nausea 
through the mechanism of altered mood, which can in turn impact the report of symptom severity 
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(Salovey, Rothman, Detweiler, & Steward, 2000).  In other words, sad mood may potentially 
color individuals’ sensitivity to physiological cues, and the amelioration of such sad mood 
through BLT could readily account for the finding of a decrease in reported physiological 
symptoms (side effects) among participants who entered the study with elevated depressive 
symptoms.  Certainly, future studies should further examine this possibility.   
The present study has numerous limitations.  First, while a single-session light exposure 
allows for a high degree of experimental control, it does not reflect the common usage of BLT, 
which is often applied on numerous consecutive days for a span of several weeks at a time.  
While previous findings suggest the report of side effects tends to diminish with repeated 
exposure (Kogan & Guilford, 1998), the full array of potential side effects for each participant 
may not have been triggered by a single session’s exposure in the present investigation.  Further, 
the study sample was relatively young, with low mean baseline levels of undesired physical 
symptoms (as assessed by the study’s side effects measure), sad mood, and depressive 
symptomatology.  It would be desirable in any attempted replication, therefore, to include 
participants with a broader range of ages, including older individuals who may express greater 
variability in undesired physical symptoms. 
This study also appears to be somewhat limited from the standpoint of its practical 
significance.  Although the observed reductions in sad mood and nausea severity were 
statistically significant, they may be too small to be of practical utility.  The average difference in 
the reduction of sad mood between the BLT group and the control group was only 0.40 on an 8-
point scale.  Such a change may be too minimal to be perceived by an individual as beneficial.  
Similarly, there was a low baseline prevalence of nausea in the study, with only three individuals 
in each light condition endorsing nausea at pre-treatment.  Thus, the study’s result of a potential 
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anti-nausea effect of BLT among dysphoric participants requires replication with a sample 
characterized by a higher prevalence of nausea.  Likewise, it would be valuable to see an 
attempted replication among individuals with higher baseline levels of sad mood. 
The strengths of this study lie in its use of a placebo group and the relatively large sample 
size for a placebo-control examination of BLT-related effects.  Also, this study controls for 
physical symptoms present before light exposure, thereby permitting an examination of the 
directionality of side effect severity.  Commonly, studies of side effects only examine prevalence 
rates after intervention – i.e., only the emergence or remission of symptoms rather than their 
increase or decrease in severity, as this study did.  Furthermore, this study examined the side 
effect profile associated with the currently accepted dosage of BLT (10,000 lux) in a non-clinical 
sample, thereby addressing a significant research question which up to this point had not been 
examined.   
 The present findings demonstrate the importance of understanding the full extent of 
potential adverse effects of BLT, a significant area of investigation given the increasing 
frequency with which BLT is being used in both clinical and non-clinical settings.  These results 
also indicate that the reported prevalence of acute adverse side effects in the extant clinical 
literature may not apply fully to non-clinical populations.  After one exposure of BLT, change in 
total symptom intensity and nausea severity was ameliorated for those with higher scores on 
depressive symptomatology.  Furthermore, no increase in headache or blurred vision emerged in 
the present investigation.  Only eye strain showed a significant exacerbation from pre-treatment 
to post-treatment, but it occurred in both the bright white light and the control groups.  These 
findings suggest that BLT may be more tolerable, with fewer side effects, when employed with 
non-clinical, as opposed to clinical, populations.  While these findings provide support for the 
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high tolerability of BLT, further research is needed to determine the extent to which the results 
may extend beyond young, non-clinical samples.   
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Table 1 
Baseline characteristics of participants in red light and white light conditions 
Condition Min Max Mean SD t 
Red 
(n=77) 
Age 18 31 19.45 1.80 - 
Hours of Sleep   3 13   6.84 1.48 - 
ISI    0 17   6.35 4.11 - 
QUIDS   0 21   5.25 4.30 - 
Nausea intensity   0   3   0.09 0.46 - 
Headache intensity   0   4   0.38 0.95 - 
Blurred vision intensity   0   4   0.17 0.64 - 
Eye Strain intensity   0   5   0.13 0.62 - 
Total side effect intensity   0 30   3.94 5.82 - 
Anxiety   0   4   0.36 0.94 - 
Sad Mood   0   4   0.42 0.85 - 
Positive Affect   0 19   8.50 5.04 - 
Negative Affect   0   6   0.78 1.54 - 
White 
(n=71) 
Age 18 29 19.56 1.97 - 
Hours of Sleep   3 12   6.85 1.62 - 
ISI    0 20   5.93 4.47 - 
QUIDS   0 20   6.35 4.89 - 
Nausea intensity   0   3   0.07 0.39 - 
Headache intensity   0   4   0.45 0.91 - 
Blurred vision intensity   0   1   0.04 0.20 - 
Eye Strain intensity   0   3   0.08 0.41 - 
Total side effect intensity   0 25   4.73 5.33 - 
Anxiety   0 12   0.58 1.72 - 
Sad Mood   0   5   0.69 1.24 - 
Positive Affect   0 20   8.55 4.77 - 
Negative Affect   0 13   1.27 2.47 - 
Total 
(N=148) 
Age 18 31 19.51 1.88 -0.351 
Hours of Sleep   3 13   6.84 1.55 -0.043 
ISI    0 20   6.15 4.28  0.597 
QUIDS   0 21   5.78 4.61 -1.463 
Nausea intensity   0   3   0.07 0.39  0.289 
Headache intensity   0   4   0.45 0.91 -0.485 
Blurred vision intensity   0   1   0.04 0.20  1.602 
Eye Strain intensity   0   3   0.08 0.41  0.525 
Total side effect intensity   0 25   4.73 5.33 -0.867 
Anxiety   0 12   0.58 1.72   0.947 
Sad Mood   0   5   0.69 1.24 -1.585 
Positive Affect   0 20   8.55 4.77 -0.061 
Negative Affect   0 13   1.27 2.47 -1.456 
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Table 2 
Prevalence of side effects for each condition pre-treatment and post-treatment 
 Pre-Treatment Post-Treatment 
 Red White Red White 
Nervousness 27 (35%) 24 (34%)   8 (10%) 11 (16%) 
Agitation   5 (7%) 12 (17%)   8 (10%) 11 (16%) 
Tremor or shakiness   4 (5%)   4 (6%)   4 (5%)   4 (6%) 
Muscle twitching 10 (13%)   6 (9%)   4 (5%)   3 (4%) 
Abdominal pain   8 (10%)   4 (6%)   5 (7%)   2 (3%) 
Upset stomach   9 (12%) 12 (17%)   7 (9%)   8 (11%) 
Nausea   3 (4%)   3 (4%)   5 (7%)   0 
Weakness or fatigue 22 (29%) 21 (30%) 26 (33%) 21 (30%) 
General dizziness   4 (5%)   6 (9%) 10 (13%)   6 (9%) 
Daytime drowsiness 23 (30%) 30 (42%) 32 (42%) 33 (47%) 
Sweating   8 (10%)   7 (10%)   2 (3%)   2 (3%) 
Flushing   1 (1%)   1 (1%)   1 (1%)   0 
Headache 12 (16%) 18 (25%) 22 (29%) 22 (31%) 
Blurred vision   7 (9%)   3 (4%)   8 (10%)   9 (13%) 
Eye strain   6 (8%)   4 (6%) 20 (26%) 17 (24%) 
Dry mouth   8 (10%) 10 (14%) 10 (13%) 10 (14%) 
Irritability   9 (12%) 10 (14%)   7 (9%)   5 (7%) 
Restless energy   8 (10%) 10 (14%) 13 (17%) 11 (16%) 
Average number of side effects   2.26   2.49   2.61   2.46 
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Table 3 
Results of regression analyses 
  b SE b     β 
Regression 1 (total severity)     
*Step 1 Constant  .255  .528  
 Condition -.674  .765 -.072 
 QIDS -.228  .083 -.222** 
     
***Step 2 Constant  .389  .518  
 Condition -.687  .747 -.073 
 QIDS  .023  .120  .022 
 Condition*QIDS -.461  .163 -.330** 
     
Regression 2 (nausea)     
Step 1 Constant  .007  .056  
 Condition -.071  .082 -.072 
 QIDS -.012  .009 -.107 
     
*Step 2 Constant  .020  .055  
 Condition -.072  .080 -.073 
 QIDS  .013  .013  .124 
 Condition*QIDS -.046  .017 -.313* 
     
Regression 3 (headache)     
Step 1 Constant  .013  .097  
 Condition  .070  .141  .041 
 QIDS -.023  .015 -.127 
     
Step 2 Constant  .010  .098  
 Condition  .071  .141  .042 
 QIDS -.030  .023 -.160 
 Condition*QIDS  .011  .031  .044 
     
Regression 4 (blurred vision)     
Step 1 Constant  .016  .059  
 Condition  .107  .086  .103 
 QIDS  .006  .009  .057 
     
Step 2 Constant  .005  .059  
 Condition  .108  .085  .105 
 QIDS -.014  .014 -.128 
 Condition*QIDS  .038  .018  .250 
     
Regression 5 (eye strain)     
Step 1 Constant  .348  .069  
 Condition -.021  .139 -.013 
 QIDS  .020  .015  .107 
     
Step 2 Constant  .350  .097  
 Condition -.021  .139 -.013 
 QIDS  .024  .022  .131 
 Condition*QIDS -.008  .030 -.032 
Note: * p < .05.  ** p < .01.  *** p = .001 
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Table 4 
Means and standard deviations for average side effect intensity 
 Red White Total 
 M SD M SD M SD 
Pre 3.94 5.82 4.73 5.33 4.32 5.59 
Post 4.31 6.03 4.18 4.52 4.25 5.34 
Note: Pre = pre-treatment. Post = post-treatment 
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Table 5 
Results of 2x2 repeated measures ANOVA including main effects for time (pre, post), main 
effects for condition (red, white), and the interaction effects of time-by-condition 
Variable Time Condition Interaction 
Negative affect 14.973*** 2.411 1.980 
Positive affect 11.344** 0.653 0.694 
Anxiety 10.381** 2.372 0.091 
Sad mood   6.318* 0.643 4.624* 
 Note: F values provided. * p < .05.  ** p < .01.  *** p = .001.   
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Figure 1.  Relationship between total side effect severity from bright white light versus dim red 
light across individuals with low and high levels of QIDS.  For those with high QIDS scores, 
bright white light decreases intensity of side effects, while dim red light does not. 
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Figure 2.  Relationship between nausea intensity from bright white light versus dim red light 
across individuals with low and high levels of QIDS.  For those with high QIDS scores, bright 
white light decreases nausea severity, while dim red light does not. 
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Figure 3.  Decrease in sad mood over time in response to bright white light versus dim red light.  
Sad mood decreases at a greater rate in the bright white light group than the dim red light group. 
